Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 14Not yet recruiting 8Completed 2Terminated 1

Sponsor Class

OTHER 16INDUSTRY 8NIH 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 6Colorectal Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Kaposi 2Rectal Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lung Neoplasms 2Inflammatory Bowel Diseases 2Head and Neck Neoplasms 2HIV Infections 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urinary Tract Infections 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Renal Insufficiency 1Recurrence 1Radiation Injuries 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1

Interventions

Fluorouracil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER_GOV × Nasopharyngeal Carcinoma × Clear all
NCT00563862 2011-06-16

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Hospital Authority, Hong Kong

Phase NA Terminated
465 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡